Ludwig E H, Borecki I B, Ellison R C, Folsom A R, Heiss G, Higgins M, Lalouel J M, Province M A, Rao D C
Department of Human Genetics, University of Utah, Salt Lake City 84112, USA.
Ann Epidemiol. 1997 Jan;7(1):3-12. doi: 10.1016/s1047-2797(96)00105-6.
Angiotensin-converting enzyme (ACE) and angiotensinogen (AGT) are major components of the renin-angiotensin systems. An association between myocardial infarction (MI) and the ACE DD genotype of the insertion/deletion (ID) polymorphism in intron 16 of the ACE gene has been reported. However, other similarly designed studies have not found such an association. Angiotensin II, the product of AGT, has a direct effect on vascular tone; and a variant in the AGT gene has been found to be associated with MI in the Japanese. This case-control study was initiated to investigate whether the ACEI/D and AGT M235T polymorphisms are associated with an increased risk for coronary heart disease (CHD) and MI. Our study groups were composed of participants in the National Heart Lung Blood Institute (NHLBI) Family Heart Study (FHS) selected from three population-based studies: two Atherosclerosis Risk in Communities (ARIC) centers (Forsyth County, NC, and Minneapolis, MN), and the Framingham Heart Study. In multivariate analysis within ARIC Caucasians, a significant positive association was found between CHD (controls = 230, cases = 232) and the AGT TT genotype (P = 0.022; OR = 1.84, 1.09-3.10 95% CI). When we restricted the analysis to a low-risk group for CHD (controls = 70, cases = 35) an interaction between the ACE DD and AGT TT genotypes was significant (P = 0.025; OR = 5.02 1.22-20.6 95% CI). After further subsetting low-risk cases to those with a definite MI (controls = 74, cases = 16), we found that the associations with the ACE DD genotype was also significant (P = 0.013, OR = 3.94, 1.28-12.2 95% CI). Comparable tests in the Framingham sample failed to support an association of these markers with CHD. In conclusion, within selected groups the ACE D and AGT 235T alleles are statistically associated with CHD and MI, and there is a synergistic interaction between the two alleles. These results and those from previous studies together suggest that the association of these two loci is neither strong nor consistent and involves a complex interaction among risk factors and genotypes.
血管紧张素转换酶(ACE)和血管紧张素原(AGT)是肾素-血管紧张素系统的主要组成部分。有报道称心肌梗死(MI)与ACE基因第16内含子插入/缺失(ID)多态性的ACE DD基因型之间存在关联。然而,其他类似设计的研究并未发现这种关联。AGT的产物血管紧张素II对血管张力有直接影响;并且在日本人中发现AGT基因的一个变异与MI有关。开展这项病例对照研究是为了调查ACE I/D和AGT M235T多态性是否与冠心病(CHD)和MI风险增加相关。我们的研究组由从三项基于人群的研究中选取的美国国立心肺血液研究所(NHLBI)家族心脏研究(FHS)的参与者组成:两个社区动脉粥样硬化风险(ARIC)中心(北卡罗来纳州福赛斯县和明尼苏达州明尼阿波利斯),以及弗雷明汉心脏研究。在ARIC白人的多变量分析中,发现CHD(对照组 = 230,病例组 = 232)与AGT TT基因型之间存在显著正相关(P = 0.022;OR = 1.84,95% CI为1.09 - 3.10)。当我们将分析限制在CHD低风险组(对照组 = 70,病例组 = 35)时,ACE DD和AGT TT基因型之间的相互作用显著(P = 0.025;OR = 5.02,95% CI为1.22 - 20.6)。在将低风险病例进一步细分为确诊为MI的病例(对照组 = 74,病例组 = 16)后,我们发现与ACE DD基因型的关联也很显著(P = 0.013,OR = 3.94,95% CI为1.28 - 12.2)。在弗雷明汉样本中的类似检测未能支持这些标志物与CHD的关联。总之,在选定的组中,ACE D和AGT 235T等位基因在统计学上与CHD和MI相关,并且这两个等位基因之间存在协同相互作用。这些结果以及先前研究的结果共同表明,这两个基因座的关联既不强烈也不一致,并且涉及风险因素和基因型之间的复杂相互作用。